Elekta (OTCMKTS:EKTAY) Stock Price Down 1.7% - What's Next?

Elekta AB (OTCMKTS:EKTAY - Get Free Report)'s stock price dropped 1.7% during trading on Tuesday . The company traded as low as $4.87 and last traded at $4.87. Approximately 3,652 shares traded hands during mid-day trading, a decline of 21% from the average daily volume of 4,639 shares. The stock had previously closed at $4.96.

Analyst Upgrades and Downgrades

Separately, Danske downgraded shares of Elekta to a "hold" rating in a research report on Tuesday, June 3rd.

Elekta Stock Performance

The stock's 50-day moving average price is $5.11 and its 200-day moving average price is $5.33. The company has a debt-to-equity ratio of 0.70, a quick ratio of 0.86 and a current ratio of 1.09. The company has a market capitalization of $1.90 billion, a price-to-earnings ratio of 99.02 and a beta of 1.20.

Elekta (OTCMKTS:EKTAY - Get Free Report) last posted its quarterly earnings results on Wednesday, May 28th. The company reported $0.11 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.13 by ($0.02). Elekta had a net margin of 1.15% and a return on equity of 11.55%. The company had revenue of $503.22 million for the quarter, compared to analyst estimates of $507.19 million. As a group, equities research analysts expect that Elekta AB will post 0.36 earnings per share for the current year.

About Elekta

Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity for real-time MR visualization; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for image guided radiation therapy; treatment and workflow management solutions; radiation and medical oncology; and other patient services.